文献速递湿疹皮炎与荨麻疹银屑病与炎症性皮肤病

超氧化物歧化酶3抑制LL-37/KLK-5介导的皮肤炎症

Superoxide Dismutase 3 Inhibits LL-37/KLK-5-Mediated Skin Inflammation through Modulation of EGFR and Associated Inflammatory Cascades.
PubMed 文献 · J Invest Dermatol · 2019-08-26

本研究在体外和体内探讨超氧化物歧化酶3(SOD3)对LL-37或KLK-5诱导的皮肤炎症的作用及机制。结果显示SOD3可显著减少LL-37和KLK-5诱导的促炎介质表达,抑制角质形成细胞中EGFR、PAR2、NLRP3及p38/ERK通路活化,并改善SOD3敲除小鼠及野生型小鼠的KLK-5诱导炎症。

要点

  • SOD3在体外显著抑制LL-37和KLK-5诱导的角质形成细胞促炎介质表达。
  • SOD3抑制EGFR、PAR2、NLRP3及p38/ERK信号通路活化。
  • SOD3可改善SOD3敲除小鼠和野生型小鼠的KLK-5诱导皮肤炎症。

核心结论

  • SOD3可能是治疗LL-37和KLK-5诱导皮肤炎症的潜在有效疗法。

研究设计与样本

  • 体外实验:在人角质形成细胞和肥大细胞中研究SOD3对LL-37或KLK-5诱导炎症的作用。
  • 体内实验:在SOD3敲除小鼠和野生型小鼠中皮下注射KLK-5并给予SOD3治疗。

主要发现

  • SOD3显著减少LL-37和KLK-5诱导的促炎介质表达。
  • SOD3抑制人角质形成细胞中EGFR、蛋白酶激活受体2、NLRP3及p38/细胞外信号调节激酶信号通路活化。
  • SOD3抑制肥大细胞中LL-37诱导的炎症介质表达、活性氧产生及p38/ERK活化。
  • SOD3敲除小鼠皮下注射KLK-5出现红斑、表皮增厚、肥大细胞和中性粒细胞浸润、炎症介质表达及EGFR、PAR2、NLRP3和下游MAPK通路活化。
  • 在SOD3敲除小鼠和野生型小鼠中给予SOD3可挽救或改善KLK-5诱导的炎症级联反应。

临床怎么用

  • SOD3可能作为LL-37/KLK-5相关皮肤炎症(如特应性皮炎、银屑病、玫瑰痤疮)的候选抗炎策略。

局限性

  • 原文未报告具体样本量、统计阈值及临床研究数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The expressions of LL-37 and KLK-5 were found to be altered in various dermatoses, including atopic dermatitis, psoriasis, and rosacea. However, the downstream inflammatory effect of LL-37 and KLK-5 is not as well studied. In addition, there is little high-quality evidence for the treatment of LL-37- and KLK-5-mediated inflammation. In this study, we investigated the effect of superoxide dismutase 3 (SOD3) on LL-37- or KLK-5-induced skin inflammation in vitro and in vivo and its underlying anti-inflammatory mechanisms. Our data showed that SOD3 significantly reduced both LL-37- and KLK-5-induced expression of pro-inflammatory mediators and suppressed the activation of EGFR, protease-activated receptor 2, nucleotide-binding domain, leucine-rich-containing family, pyrin domain-containing-3, and p38/extracellular signal-regulated kinase signaling pathways in human keratinocytes. Moreover, SOD3 suppressed LL-37-induced expression of inflammatory mediators, reactive oxygen species production, and p38/extracellular signal-regulated kinase activation in mast cells. In addition, subcutaneous injection of KLK-5 in SOD3 knockout mice exhibited erythema with increased epidermal thickness, mast cell and neutrophil infiltration, expression of inflammatory mediators, and activation of EGFR, protease-activated receptor 2, nucleotide-binding domain, leucine-rich-containing family, pyrin domain-containing-3, and downstream mitogen-activated protein kinase pathways. However, treatment with SOD3 in SOD3 knockout mice rescued KLK-5-induced inflammatory cascades. Similarly, KLK-5-induced inflammation in wild-type mice was also ameliorated when treated with SOD3. Taken together, our data suggest that SOD3 is a potentially effective therapy for both LL-37-and KLK-5-induced skin inflammation.

来源:J Invest Dermatol,查看原文。版权归原作者所有。

引用

  1. Agrahari G, Sah SK, Nguyen CT, et al. Superoxide Dismutase 3 Inhibits LL-37/KLK-5-Mediated Skin Inflammation through Modulation of EGFR and Associated Inflammatory Cascades. J Invest Dermatol. 2019. PMID: 31465746. doi:10.1016/j.jid.2019.08.434

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。